Vivera Welcomes Seasoned Publicist Amanda Whitcroft as Director of Public Relations
NEWPORT BEACH, Calif.—Veteran publicist Amanda Whitcroft joins Vivera’s team as Director of Public Relations. In her new role, she will utilize her experience and expansive
Powerful Addiction Documentary “People Like You” Premiers on Streaming
NEWPORT BEACH, Calif–Vivera Cares and Happy Now Films announce the streaming release of People Like You, a feature-length documentary told through the eyes of those
Vivera Welcomes Saurabh Radhakrishnan to its Advisory Board
NEWPORT BEACH, Calif.–Vivera is pleased to welcome Mr. Saurabh Radhakrishnan to the Company’s Advisory Board. Mr. Radhakrishnan will support Vivera in its development and commercialization initiatives
TABMELT Granted Patent Allowance in Israel, Expanding Vivera’s Global Licensing Reach
NEWPORT BEACH, Calif. — Vivera is pleased to announce the expansion of its exclusive global license to the novel TABMELT® platform for pharmaceutical use in
Vivera Enters $6B Market with Speech Assessment and Feedback Device Patent Allowance
NEWPORT BEACH, Calif.—Vivera is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has issued a U.S. patent allowance for the Company’s Speech
Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board
NEWPORT BEACH, Calif. – Vivera is pleased to welcome Lea Ramirez to the Company’s Advisory Board. Ms. Ramirez joins Vivera’s Advisory Board to assist with
Investor Relations and Media Inquiries:
Investor Inquiries:
[email protected]
Media Inquiries:
[email protected]
Forward-looking and cautionary statements:
Statements made on our website may contain “forward-looking information” as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of Vivera, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of Vivera and its subsidiaries as a going concern, general economic and market conditions, price of biomass, the accuracy of production resource estimates, and the performance of Vivera’s future operations. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. Important factors that could cause actual results to differ materially from Vivera’s expectations include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. For additional information with respect to risk factors applicable to Vivera, reference should be made to Vivera’s continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, Vivera’s CSE Listing Statement. The forward-looking information contained on our website is made as of the date of the release of such statement and Vivera does not intend, and expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The CSE has not reviewed, approved or disapproved the contents on our site.
